Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients (Q36213915)

12 August 2017

Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients (English)

1 reference

12 August 2017

1 reference

Wen-Pin Su

1

1 reference

12 August 2017

Chi-Chung Wen

2

1 reference

12 August 2017

Chao-A Hsiung

3

1 reference

12 August 2017

Ih-Jen Su

4

1 reference

12 August 2017

Ann-Lii Cheng

5

1 reference

12 August 2017

Ming-Chih Chang

6

1 reference

12 August 2017

Chao-Jung Tsao

7

1 reference

12 August 2017

Woei-Yao Kao

8

1 reference

12 August 2017

Wu-Ching Uen

9

1 reference

12 August 2017

Chiun Hsu

10

1 reference

12 August 2017

Chih-Hung Hsu

11

1 reference

12 August 2017

Yen-Shen Lu

12

1 reference

12 August 2017

Hwei-Fan Tien

13

1 reference

12 August 2017

Tsu-Yi Chao

14

1 reference

12 August 2017

Li-Tzong Chen

15

1 reference

12 August 2017

Jacqueline Whang-Peng

16

1 reference

12 August 2017

Pei-Jer Chen

17

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

World Journal of Gastroenterology

12 August 2017

1 reference

12 August 2017

11

1 reference

12 August 2017

34

1 reference

12 August 2017

5283-5288

1 reference

Natural history and prognosis of hepatitis B.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Prognostic factors in cirrhosis identified by Cox's regression model.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Molecular Epidemiology of Hepatitis B Viral Serotypes and Genotypes in Taiwan

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622796

Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan

5 December 2018

1 reference

12 December 2020

Hepatitis viruses under immunosuppressive agents

1 reference

12 December 2020

Hepatitis B infection in patients with lymphomas

1 reference

12 December 2020

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

12 December 2020

Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C

1 reference

12 December 2020

Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis

1 reference

12 December 2020

Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders

1 reference

12 December 2020

Hyperglobulinaemia in liver disease

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I34.5283

1 reference

release_lzyhav27gjdhljcnxa6emskcja

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lzyhav27gjdhljcnxa6emskcja

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

16149133

1 reference